PRNewsWire - Health

BrightGene Presents Positive Phase 2 Data for Dual GLP-1R/GIPR Agonist for Weight Management and Type 2 Diabetes and Preclinical Data for Novel Amylin Analog at American Diabetes Association's 85th Scientific Sessions
FDA's Accelerated Drug Review Plan Praised by Former Senior Trump Health Official
AARP SEEKS 2025 ANDRUS AWARD FOR COMMUNITY SERVICE NOMINEES
DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of McLaren Health Care Customers Whose Data May Have Been Compromised